Cargando…
SEOM clinical guidelines for the treatment of advanced prostate cancer (2020)
The treatment of advanced prostate cancer has evolved due to recent advances in molecular research and new drug development. Dynamic aberrations in the androgen receptor, DNA repair genes, PTEN-PI3K, and other pathways drive the behavior of advanced prostate cancer allowing a better selection of the...
Autores principales: | González del Alba, A., Méndez-Vidal, M. J., Vazquez, S., Castro, E., Climent, M. A., Gallardo, E., Gonzalez-Billalabeitia, E., Lorente, D., Maroto, J. P., Arranz, J. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057980/ https://www.ncbi.nlm.nih.gov/pubmed/33625671 http://dx.doi.org/10.1007/s12094-021-02561-5 |
Ejemplares similares
-
SEOM Clinical guidelines for the treatment of metastatic prostate cancer
por: Cassinello, J., et al.
Publicado: (2014) -
SEOM clinical guidelines for the management of germ cell testicular cancer (2016)
por: Aparicio, J., et al.
Publicado: (2016) -
SEOM clinical guideline for treatment of kidney cancer (2017)
por: Gallardo, E., et al.
Publicado: (2017) -
SEOM clinical guideline in ovarian cancer (2020)
por: Redondo, A., et al.
Publicado: (2021) -
SEOM clinical guidelines for the treatment of metastatic prostate cancer (2017)
por: Cassinello, J., et al.
Publicado: (2017)